Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
137 studies found for:    "juvenile idiopathic arthritis" OR "Arthritis, Juvenile Rheumatoid"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"juvenile idiopathic arthritis" OR "Arthritis, Juvenile Rheumatoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
2 Completed
Has Results 		Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Conditions: Juvenile Chronic Polyarthritis;   Juvenile Idiopathic Arthritis;   Juvenile Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: methotrexate - etanercept - prednisolone arm
3 Active, not recruiting Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis;   JIA
Interventions: Biological: adalimumab;   Drug: Methotrexate
4 Completed Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
5 Terminated
Has Results 		A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CNTO 148 (Golimumab);   Drug: Placebo;   Drug: Methotrexate
6 Unknown † Cost of Care for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Completed Active Juvenile Idiopathic Arthritis (JIA)Compassionate Use
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Adalimumab
8 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
9 Recruiting Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Genetic: Blood test
10 Terminated
Has Results 		Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
11 Unknown † Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
12 Completed Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Device: Galileo (whole body vibration (WBV) therapy)
13 Not yet recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
14 Unknown † Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
15 Recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
16 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
17 Completed
Has Results 		Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
18 Completed Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Condition: Systemic-Onset Juvenile Idiopathic Arthritis
Interventions: Drug: Anakinra;   Biological: Pneumo23
19 Active, not recruiting Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
20 Recruiting Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Temporomandibular Arthritis
Intervention:
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years